Mission
OUR MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES.
Public Charity
BLOOD CANCER UNITED INC
BLOOD CANCER UNITED INC is a nonprofit organization categorized as Public Charity based in WASHINGTON, DC. Its most recent IRS filing (2025) reports revenue of $358.7M, expenses of $398.1M, total assets of $532.2M. Imperigo tracks 2,260 reported grant relationships connected to this organization totaling approximately $196.7M.
EIN: 135644916
WASHINGTON, DC
Cancer
NTEE: G30
Latest filing: 2025
Total Revenue$358.7M
Total Expenses$398.1M
Total Assets$532.2M
Grant Records2,260
Funding Total$196.7M
Filing Years2021–2025
Where $100 goes at Blood Cancer United Inc
How Blood Cancer United Inc divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$76
Programs
the work itself
$12
Management
running the organization
$12
Fundraising
raising the next dollar
Inside the $76 for programs
$33
A) research programs:at Blood Cancer United, we are pushing boundaries toward powerful new therapies
$32
B) patient & community services:an estimated 1.7 million people across the united states (us) are currently living with or are in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes…
$7
C) public health education
Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL SUPPORT
$1,704,078
CONTRIBUTION
$575,000
2025 MISC GRANTS TO CHARITY
$508,293
Research & patient services
$165,000
LEUKEMIA RESEARCH
$160,000
Showing up to 5 of 2,260 total records — full history available with membership.
Officers & Directors
CHAIR
Alessandra Tocco
BOD MEMBER
Alex Okafor
SVP, BUS OPS AND TECHNOLOGY
Andrew Perry
BOD MEMBER
Ari Melnick
FORMER EVP, GEN CNSL - END 05/2024
Dale Nissenbaum
PRESIDENT & CEO
E Anders Kolb
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $358.7M | $398.1M | $532.2M |
| 2024 | $368.2M | $371.8M | $602.0M |
| 2023 | $378.3M | $386.1M | $643.9M |
| 2022 | $427.0M | $518.6M | $693.7M |
| 2021 | $477.7M | $359.8M | $743.6M |
Between 2021 and 2025, reported annual revenue declined from $477.7M to $358.7M (-25%), with total assets most recently reported at $532.2M.
Interactive year-over-year charts and full filing details available with membership.